Eurazeo PME

Eurazeo PME is a private equity investment firm based in Paris, France, and serves as a subsidiary of Eurazeo. Established in 2006, it focuses on investing in small and medium-sized enterprises (SMEs) in France with a valuation of less than €200 million. The firm takes a long-term approach as a professional shareholder, providing financial, human, and organizational resources to support the transformation and sustainable growth of its portfolio companies. Eurazeo PME emphasizes responsible investment practices, guided by its corporate social responsibility policy. Its portfolio includes well-established companies such as Dessange International, Léon de Bruxelles, and Smile, which benefit from experienced management teams and solid market positions. In 2016, Eurazeo PME reported a consolidated turnover of €965 million, reflecting its commitment to enhancing the growth potential of SMEs in the French market.

Vivianne Akriche

Managing Director, New York

Amandine Ayrem

Principal

Maxime de Bentzmann

Principal

Alice Besomi

Investment Director - Climate Fund

George Birman

Associate and Principal, Eurazeo Brands

Nathalie Bruls

Managing Director

David Choi

Principal, Eurazeo Brands

Alina Costica DiMeglio

Principal

Henri Domange

Principal

Laurent Droin

Managing Director, Eurazeo Brands

Hala Fadel

Managing Director - Growth

Marc Frappier

Managing Partner and Head of Eurazeo Capital

Jill Granoff

CEO of Eurazeo Brands

Benoist Grossmann

CEO Eurazeo Investment Manager

Edouard Guigou

Managing Director

Patrice Henry

Operating Partner

Francois Lacoste

Managing Partner - Head of Private Debt

Antonin Marcus

Principal

Julien Mialaret

Operating Partner

Nicolas Nedelec

Managing Director - Private Debt

Francesco Orsi

Managing Director

Wilfried Piskula

Managing Director

Louis Prothery

Managing Director

Yann du Rusquec

Managing Director - VC and Growth

Eric Schaefer

Managing Director, New York

Paul Vaisse

Investment Director, Investments

Benjamin Hara

Partner

Past deals in Benelux

Vico Therapeutics

Series B in 2024
Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Vico Therapeutics

Series B in 2024
Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

Etix Everywhere

Private Equity Round in 2023
Etix Everywhere is a fast-growing startup financing, designing, building and operating innovative data centers. Based in Luxembourg, the company offers colocation services in its global data center network, builds tailor-made data centers. With 50% of staff dedicated to R&D, Etix Everywhere develops smart devices & softwares to empower data centers with Artificial Intelligence.

Ikaros Solar

Acquisition in 2022
The Ikaros Solar group is an international leader in the photovoltaic market. The group has operational companies in Belgium, the Netherlands, the United Kingdom, Portugal, India and Mexico. Its activities include the installation of turnkey photovoltaic solutions for its business customers and specialised investors. The group also distributes high-quality products to installation contractors.

Bird

Series C in 2021
MessageBird powers communication between businesses and their customers — across any channel, always with the right context, and on every corner of the planet. Its products and solutions are the foundational building blocks to business communications across preferred channels, like SMS, Voice, WhatsApp, WeChat, Messenger, Email and more. Founded in Amsterdam in 2011, MessageBird connects to billions of devices and is trusted by nearly 20,000 customers. It operates across nine worldwide hubs and is proud to be a “Work Anywhere” company.

Keesing Media Group

Venture Round in 2021
Keesing Media Group publishes puzzle magazines in Europe. It offers puzzle magazines in various languages and countries, including the Netherlands, Belgium, Denmark, Germany, France, Spain, and Sweden. The company also provides apps for the iPad and other tablets for publishing puzzles. Keesing Media Group B.V. was founded in 1911 and is based in Amsterdam, the Netherlands. The company has additional offices in Paris, Naintré, Antwerp, Amsterdam, and Copenhagen.

PePe Parts

Seed Round in 2020
PePe Parts is the full-service B2B e-commerce platform for the sale and distribution of scooter and moped (technical) parts and accessories in the Netherlands. Pe-Pe Parts serves the aftermarket via a dispersed network of over ~1,500 dealers, garages, resellers, and fleet owners. The company imports and distributes a wide variety of original parts and accessories from a broad range of renowned brands (e.g., Piaggio, Vespa, Yamaha, and Peugeot) and designs and distributes custom-made parts and accessories under its own brand DMP. In addition, Pe-Pe Parts is a specialist in old-timer parts and accessories.

AM Pharma

Seed Round in 2020
AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Groupe Berkem

Seed Round in 2018
With more than 50 years of experience in plant extraction and chemical formulation, Groupe Berkem is active in three business areas developed around the production of natural assets: Plant extraction for cosmetics and food processing, which accounts for 33% of turnover (Berkem SAS); Production of wood processing compounds for 47% of sales (S & C Construction SAS and Sarpap & Cecil Industrie SAS); The distribution of its wood treatment products to construction and building professionals via a branch network for 20% of turnover (T & G Distribution). These four companies are structured around the leading holding, Berkem Développement SAS, whose head office is based in Dordogne. The Group's activities are spread over four sites in France and Belgium. The Group dedicates € 3m each year to R & D, which enables it to maintain a permanent innovation in the development of its products but also to optimize its production tools and in particular to massively reduce its fossil energy consumption and its volume. of waste.

IMV Technologies

Private Equity Round in 2010
Founded in 1963 and based in L’Aigle in the French region of Normandy, IMV Technologies is the global leader in biotechnologies for animal artificial insemination. Recognized worldwide for the quality of its products, the group’s development is based on the conception of new technologies and expertise for artificial insemination techniques. With five foreign subsidiaries (US, India, China, Italy and the Netherlands) and a network of distributors across more than 120 countries, IMV Technologies generates almost 80% of its revenue abroad and has around 450 employees.

Mors Smitt Holding

Acquisition in 2006
Mors Smitt Holding offers railway relays and related technology, industrial relay technology, and maritime bridge instrumentation solutions. It offers rolling stock that includes relays, protection relays, hall effect sensors, miniature circuit breakers, traction energy management solutions, integrated electrical solutions, speedometers and panel indicators, and door control units; signaling and infrastructure products, such as protection relays, hall effect sensors, miniature circuit breakers, safety critical relays, signaling relays, protection components, retrofit and replacement solutions, and maintenance and test equipment. The company also supplies products and services for the industrial segments, including heavy duty and general purpose relays, surge protection devices, portable test and measuring equipment for installation and appliance safety, climate control components, bridge (wing) instruments, and control (rudder) room instruments, as well as offers technical support and services, and repairing services. Mors Smitt Holding serves power generation, petro-chemical and water treatment plants, mining, shipbuilding and installation, and building automation markets. It offers its products through a network of professional, subsidiaries, distributors, and agents in France, the Netherlands, the United States, and Hong Kong. The company is based in Utrecht, the Netherlands with engineering and manufacturing locations in France, the Netherlands, and China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.